Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102363599A reveals a robust chiral resolution method for sitagliptin intermediates using D-di-p-toluoyl tartrate, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN117586317A reveals a novel methylation process achieving over 98% purity. This method offers significant supply chain stability and cost reduction advantages.
Patent CN117757876A reveals double-enzyme catalysis for 2'-F-dAR. Offers simplified process, cost reduction in pharmaceutical intermediates manufacturing, and high purity.
Patent CN112110811B details a novel Pd-catalyzed route for bilastine intermediates, offering high purity and scalable manufacturing for global supply chains.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Patent CN115873005B details high-purity perospirone intermediate synthesis ensuring safety and supply chain reliability for global pharmaceutical manufacturing partners.
Novel asymmetric phthalocyanine compound with RGD peptide for cancer targeting. Low phototoxicity, high purity synthesis for bio-imaging applications.
Patent CN113461648A discloses a streamlined 2-step synthesis for coumarin-based neuraminidase inhibitors, offering a cost-effective alternative to complex antiviral routes.
Novel rhodium-catalyzed pathway enhances purity and yield for sitagliptin intermediates, offering significant supply chain stability and cost reduction potential.
Novel microwave method for Rapamycin 40-hydroxy alkylation. Higher yield, lower cost. Reliable pharmaceutical intermediates supplier for large scale-up.
Patent CN112321454B reveals a streamlined synthesis for Eltrombopag intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Novel metal-free synthesis patent CN113861181B enables cost reduction in fine chemical manufacturing with high purity.
Novel 7-step synthesis for Acotiamide derivative ensures high yield and purity. Ideal for functional dyspepsia drug development. Reliable supply chain partner.
Patent CN1097419A discloses a robust route for imidazole derivatives, offering cost-effective manufacturing solutions for reliable pharmaceutical intermediate suppliers globally.
Patent CN107663185A reveals a cost-effective titanium-zinc catalyzed route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Patent CN107663185A reveals a low-cost titanium-zinc catalytic route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Novel metal-free oxidation method for carboxylic acids. Reduces cost and environmental impact for pharmaceutical and agrochemical manufacturing supply chains.
Patent CN106146379A details a high-yield S-Oxiracetam route eliminating chromatography. Discover cost-effective manufacturing and supply chain advantages.
Novel solid-liquid strategy for Galaxamide. 99% purity, 84.2% yield. Cost-effective scale-up for pharma intermediates.
Novel titanium-zinc method for butyrolactone derivative ensures high purity and scalable supply chain for epilepsy drug intermediates globally.